Dennis D. Kim is Chief Medical Officer at CymaBay Therapeutics, Inc. (CBAY). They have made 7 open-market trades across 2 companies since 2015, most recently 2023-04-17.
CIK 0001456750
3 open-market purchases totalling $139K since 2017, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBAY | SELL | 2023-04-13 | 2023-04-17 | $9.50 | $2.3M | +3.1% | -8.3% | +16.4% |
| CBAY | SELL | 2023-03-28 | 2023-03-30 | $8.99 | $899 | -2.9% | +20.3% | -10.2% |
| CBAY | BUY | 2022-01-19 | 2022-01-20 | $3.04 | $61K | +2.7% | +18.4% | -1.4% |
| ZFGN | BUY | 2017-07-11 | 2017-07-12 | $3.39 | $34K | +2.9% | -1.2% | +2.0% |
| ZFGN | BUY | 2017-05-10 | 2017-05-11 | $4.40 | $44K | -8.9% | -18.9% | -22.6% |
| ZFGN | SELL | 2015-09-15 | 2015-09-17 | $40.00 | $1.6M | -0.3% | +1.3% | +1.3% |
| ZFGN | SELL | 2015-09-14 | 2015-09-16 | $40.00 | $24K | -0.3% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.